Skip to main content

Table 1 Descriptive Characteristics of Eligible Prostate Cancer Cases Diagnosed at Age 40+ in PCR, 2004–2014

From: Spatial patterns in prostate Cancer-specific mortality in Pennsylvania using Pennsylvania Cancer registry data, 2004–2014

Variables PA
(N = 94,274)
PA Catchment Area
Catchment Area
(N = 27,357, 29.02%)
Non-Catchment Area
(N = 66,917, 70.98%)
Rural
Appalachia
(N = 3828, 13.99%)
Urban
Appalachia
(N = 6483, 23.70%)
Urban
Non-Appalachia
(N = 17,046, 62.31%)
Mean Age in years (SD)a,b 66.38 (9.38) 66.73 (9.37) 66.24 (9.38) 66.95 (9.31) 66.47 (9.31) 66.77 (9.40)
Mean Serum PSA, ng/mL (SD) a,b 12.21 (19.03) 12.43 (18.88) 12.12 (19.09) 12.97 (19.83) 13.11 (19.73) 12.04 (18.3)
Missing # 11,963 3667 8296 583 714 2370
Racen (%)a,b
 White 79,066 (83.87) 25,278 (92.40) 53,788 (80.38) 3681 (96.16) 6171 (95.19) 15,426 (90.50)
 Black 10,067 (10.68) 1038 (3.79) 9029 (13.49) 64 (1.67) 126 (1.94) 848 (4.97)
 Asian 571 (0.61) 91 (0.33) 480 (0.72) 3 (0.08) 16 (0.25) 72 (0.42)
 Other/Unknown 4570 (4.85) 950 (3.47) 3620 (5.41) 80 (2.09) 170 (2.62) 700 (4.11)
Ethnicityn (%)a,b
 Hispanic 1309 (1.39) 528 (1.93) 781 (1.17) 25 (0.65) 60 (0.93) 443 (2.60)
 Non-Hispanic 80,271 (85.15) 23,411 (85.58) 56,860 (84.97) 3057 (79.86) 5230 (80.67) 15,124 (88.72)
 Unknown 12,694 (13.47) 3418 (12.49) 9276 (13.86) 746 (19.49) 1193 (18.40) 1479 (8.68)
Insurancen (%)a,b
 Insured 76,737 (81.40) 22,045 (80.58) 54,692 (81.73) 3049 (79.65) 5296 (81.69) 13,700 (80.37)
 Uninsured 443 (0.47) 161 (0.59) 282 (0.42) 24 (0.63) 18 (0.28) 119 (0.70)
 Unknown 17,094 (18.13) 5151 (18.83) 11,943 (17.85) 755 (19.72) 1169 (18.03) 3227 (18.93)
Gleason Scoren (%)a,b
 6 40,762 (43.24) 11,768 (43.02) 28,994 (43.33) 1754 (45.82) 2762 (42.60) 7252 (42.54)
 7 37,531 (39.81) 10,725 (39.20) 26,806 (40.06) 1398 (36.52) 2550 (39.33) 6777 (39.76)
 8–10 15,525 (16.47) 4723 (17.26) 10,802 (16.14) 655 (17.11) 1140 (17.58) 2928 (17.18)
 Unknown 456 (0.48) 141 (0.52) 315 (0.47) 21 (0.55) 31 (0.48) 89 (0.52)
Tumor Stagen (%)b
 T1 37,957 (40.26) 11,118 (40.64) 26,839 (40.11) 1617 (42.24) 2532 (39.06) 6969 (40.88)
 T2 41,341 (43.85) 11,851 (43.32) 29,490 (44.07) 1639 (42.82) 2779 (42.87) 7433 (43.61)
 T3 8539 (9.06) 2477 (9.05) 6062 (9.06) 290 (7.58) 607 (9.36) 1580 (9.27)
 T4 1338 (1.42) 391 (1.43) 947 (1.42) 62 (1.62) 101 (1.56) 228 (1.34)
 Unknown 5099 (5.41) 1520 (5.56) 3579 (5.35) 220 (5.75) 464 (7.16) 836 (4.90)
Distant Metastasisn (%)b
 Yes 3580 (3.80) 1028 (3.76) 2552 (3.81) 165 (4.31) 269 (4.15) 594 (3.48)
 No 82,355 (87.36) 23,468 (85.78) 58,887 (88.00) 3141 (82.05) 5418 (83.57) 14,909 (87.46)
 Unknown 8339 (8.85) 2861 (10.46) 5478 (8.19) 522 (13.64) 796 (12.28) 1543 (9.05)
Aggressivenessn (%)a,b
 Less Aggressive 56,121 (59.53) 15,822 (57.84) 40,299 (60.22) 2217 (57.92) 3646 (56.24) 9959 (58.42)
 More Aggressive 30,931 (32.81) 9078 (33.18) 21,853 (32.66) 1174 (30.67) 2177 (33.58) 5727 (33.60)
 Unknown 7222 (7.66) 2457 (8.98) 4765 (7.12) 437 (11.42) 660 (10.18) 1360 (7.98)
Lymph Node Positiven (%)
 No 81,875 (86.85) 23,458 (85.75) 58,417 (87.30) 3153 (82.37) 5474 (84.44) 14,831 (87.01)
 Yes 2327 (2.47) 642 (2.35) 1685 (2.52) 93 (2.43) 151 (2.33) 398 (2.33)
 Unknown 10,072 (10.68) 3257 (11.91) 6815 (10.18) 582 (15.20) 858 (13.23) 1817 (10.66)
Definitive Treatment Regimenn (%)a,b
 Radiation Only 35,373 (37.52) 10,259 (37.50) 25,114 (37.53) 1294 (33.80) 2357 (36.36) 6608 (38.77)
 Primary Site Surgery Only 31,985 (33.93) 8863 (32.40) 23,122 (34.55) 1070 (27.95) 1954 (30.14) 5839 (34.25)
 Both Treatments Received 1976 (2.10) 580 (2.12) 1396 (2.09) 88 (2.30) 139 (2.14) 353 (2.07)
 Neither Treatment Received 22,707 (24.09) 6783 (24.79) 15,924 (23.80) 1271 (33.20) 1810 (27.92) 3702 (21.72)
 Unknown/Missing 2233 (2.37) 872 (3.19) 1361 (2.03) 105 (2.74) 223 (3.44) 544 (3.19)
  1. Note: 1) Rural refers to Non-Metro (RUCC≥4); Urban refers to Metro (RUCC< 4); 2) All reported percentages are column percentages; 3) PSA = Prostate-Specific Antigen (PCR documentation top-coded at 98.0 and bottom-coded at 0.1); 4) Tumor Stage was based on TNM staging system; 5) Primary Site Surgery refers only to total organ resection (radical prostatectomy not otherwise specified [NOS], total prostatectomy NOS, prostatectomy with resection in continuity with other organs, prostatectomy NOS); 6) Unknown/Missing/Other categories were not included in statistical tests of association; 7) Chi-Square tests are used for categorical characteristics and one-way ANOVA are for continuous characteristics
  2. a Significant difference between the Catchment and Non-Catchment Areas in PA
  3. b Significant associations among Appalachian-RUCC Regions within the Catchment Area